Status:
COMPLETED
Baclofen for the Treatment of Cocaine Dependence - 1
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Conditions:
Cocaine-Related Disorders
Eligibility:
All Genders
18-99 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to assess the efficacy and safety of baclofen for the treatment of cocaine dependence.
Detailed Description
Double-blind, placebo-controlled, parallel design trial of baclofen for the treatment of cocaine dependence
Eligibility Criteria
Inclusion
- Subject must have DSM-IV diagnosis of cocaine dependence.
- Subject must be seeking treatment for cocaine dependence.
- Be be able to verbalize understanding of consent form, provide written consent and verbalize willingness to complete study procedures.
Exclusion
- Please contact site for more information.
Key Trial Info
Start Date :
June 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT00082485
Start Date
June 1 2004
Last Update
January 12 2017
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
San Francisco General Hosptial
San Francisco, California, United States, 94110
2
Torrance Site
Torrance, California, United States, 90502
3
Denver VA Medical Center
Denver, Colorado, United States, 80220
4
VA Maryland Healthcare System
Baltimore, Maryland, United States, 21201